Turkey has become a much more important patent jurisdiction than many international businesses assume. Official figures published by TÜRKPATENT show that 11,394 domestic patent applications were filed in 2025, while a separate TÜRKPATENT publication citing WIPO’s 2024 data reports that Türkiye ranked 10th globally in domestic patent applications with 10,004 filings. For innovative manufacturers, engineering companies, medtech businesses, R&D-heavy exporters, investors, and startups entering the Turkish market, patent protection is therefore not a secondary compliance issue. It is a core commercial issue tied to exclusivity, valuation, licensing, litigation leverage, and market entry planning.
The legal basis of patent protection in Turkey is primarily Law No. 6769 on Industrial Property, which entered into force on January 10, 2017 and replaced the former decree-law regime for patents and other industrial property rights. TÜRKPATENT is the administrative body responsible for patent and utility model registration, related recordals, and various post-filing procedures, and it also acts as mediator in compulsory license procedures and as an expert before courts. Turkey also operates within the international patent system through the PCT framework and the European patent route, which gives applicants multiple filing paths depending on budget, timing, and jurisdictional scope.
A strong Turkish patent strategy starts with one basic point: not every innovation is best protected by a patent, and not every patent filing should take the same route. In Turkey, applicants need to think carefully about patentability, whether a utility model may be more efficient, whether to file nationally or through PCT, how early publication and provisional protection affect enforcement, whether employee invention rules affect ownership, and how non-use and compulsory license rules may influence long-term portfolio value. Turkish law offers robust tools, but it expects disciplined filing and maintenance.
The legal framework of Turkish patent law
The Industrial Property Code is the centerpiece of Turkish patent law. WIPO’s legislative record identifies the Code as Turkey’s main IP statute covering patents, utility models, trademarks, geographical indications, industrial designs, and enforcement-related matters. TÜRKPATENT’s role is not merely clerical. It registers patents and utility models, records licenses and transfers, follows the use of inventions, and cooperates internationally with other patent offices and organizations. That institutional framework matters because patent strategy in Turkey sits at the intersection of examination practice, commercialization, and court enforcement.
Turkey also has a developed enforcement environment. A recent WIPO country report describes Türkiye as having a well-functioning IP system with modern legislation, specialized IP courts, enforcement agencies, and even specialized police departments for IP infringements. The same report notes that the country continues to strengthen its industrial property portfolio and treats patents, utility models, designs, trademarks, and other rights as integral parts of its broader innovation ecosystem. For businesses, that means Turkish patent rights can be commercially meaningful when they are drafted, prosecuted, and enforced properly.
What is patentable in Turkey?
The patentability test in Turkey follows a familiar three-part structure. Article 82 of the Industrial Property Code provides that inventions in all fields of technology are patentable if they are new, involve an inventive step, and are industrially applicable. This aligns Turkey with mainstream international patent standards and makes the jurisdiction predictable for global applicants accustomed to European-style patentability analysis.
That said, Turkish law also draws clear boundaries around what does not count as a patentable invention. Article 82 states that discoveries, scientific theories, mathematical methods, plans and methods for mental activities, business methods, game rules, computer programs, aesthetic creations, literary and artistic works, scientific works, and the presentation of information are not treated as inventions for patent purposes to the extent the application relates to those subject matters as such. The same article also excludes inventions contrary to public order or morality, essentially biological processes for producing plants or animals other than microbiological processes and their products, diagnostic and treatment methods for the human or animal body, and the mere discovery of elements of the human body, including gene sequences or partial gene sequences.
These exclusions make claim drafting especially important in Turkey. A business may have a commercially valuable innovation, but unless it is framed as a patentable technical solution rather than an excluded subject matter, the filing may fail or become vulnerable later. This is particularly relevant in software-heavy sectors, health-related methods, biotech, and business-process-driven technologies. Turkish law does not reward commercial importance alone; it rewards inventions that fit within the statutory model of patentable subject matter.
Patent or utility model?
One of the most practical questions in Turkish filing strategy is whether the invention should be protected as a patent or as a utility model. Article 101 of the Code sets the protection period at 20 years from filing for patents and 10 years from filing for utility models, with no extension of those terms. TÜRKPATENT’s 2026 fee schedule mirrors that distinction by listing yearly patent maintenance fees through the 20th year and utility model fees through the 10th year.
Utility models are available for inventions that are new and industrially applicable, but the law applies a narrower subject-matter scope than for patents. Article 142 excludes chemical and biological substances, chemical and biological processes and their products, pharmaceutical substances and processes and their products, biotechnological inventions, and process inventions or products obtained by those processes from utility model protection. In addition, once a utility model is granted, there is no post-grant opposition procedure like the patent opposition mechanism under Article 99; instead, validity challenges go to court.
This means utility models can be strategically useful for mechanical, device-based, and structurally defined innovations where rapid protection matters and the subject matter falls within utility model eligibility. For more complex technologies, especially those involving chemistry, pharma, biotech, or process-heavy inventions, the patent route is usually the only viable industrial property path under Turkish law. Utility models are not simply “cheap patents.” They are a different right with different eligibility limits, a shorter term, and a different litigation posture.
Filing routes for patent protection in Turkey
There are three main practical ways to secure patent-based protection relevant to Turkey: a direct national filing before TÜRKPATENT, a PCT application followed by Turkish national-phase entry, or a European patent route combined with the Turkish translation and publication requirements that activate protection in Türkiye. Which route is best depends on the applicant’s budget, timing, filing geography, and enforcement plans.
For a direct national filing, Article 90 provides that the patent application includes the application form, description, claims, drawings referred to in the description or claims, abstract, and proof of payment of the filing fee. The same provision allows the description, claims, abstract, and drawings to be filed initially in certain foreign official languages, subject to later compliance, which can be helpful in fast-moving cross-border filings.
For applicants using the PCT route, the current WIPO PCT Applicant’s Guide for Türkiye states that the national-phase deadline is 30 months from the priority date under both PCT Article 22(1) and Article 39(1)(a), with an extension to 33 months if the applicant pays the extension fee. The guide also states that the Turkish translation must be furnished within two months from entry into the national phase, and that the national fee must generally be paid within the PCT time limit, although a short additional window is available with an extra fee. The language of proceedings in the Turkish national phase is Turkish.
A related strategic point concerns residents of Türkiye. The PCT Applicant’s Guide states that a resident of Türkiye must file an international application concerning subject matter significant for national security directly with TÜRKPATENT. That is not an issue in most commercial filings, but it is an important compliance rule for resident applicants working in sensitive technological areas.
Applicants should also remember the European patent dimension. The current WIPO PCT guidance confirms that a published European patent application designating Türkiye benefits from provisional protection from the date on which a translation of the claims has been published by TÜRKPATENT or notified to the alleged infringer. TÜRKPATENT’s fee schedule separately lists publication fees for the Turkish translation of European patent claims and the European patent specification, which shows that the European route remains an operational part of Turkish patent practice rather than a purely theoretical option.
The Turkish patent prosecution process
After filing, prosecution in Turkey moves through a defined administrative sequence. Patent and utility model applications are published at the expiration of 18 months from the filing or priority date, unless the applicant requests early publication. From publication onward, third parties may submit observations on patentability, although they do not become formal parties at that stage. This means applicants need to think not only about examiner review, but also about public scrutiny of the file once the application becomes visible.
Patent prosecution then turns on search and examination discipline. Under Article 98, once the search report is notified, the applicant must request substantive examination within three months and pay the fee, otherwise the application is deemed withdrawn. If the Office identifies problems, it may invite the applicant to file observations and amendments, but the number of such notices may not exceed three, and the applicant generally has three months to respond to each one. If the examination report concludes that the application complies with the law, the Office decides to grant the patent; if not, the application is refused.
Post-grant, Turkish patents are still open to administrative challenge. Article 99 allows third parties to oppose the grant within six months of publication of the decision to grant the patent, based on grounds such as lack of patentability, insufficiency of disclosure, or added matter. That six-month opposition window is a major strategic feature of Turkish patent law. It means grant is not automatically the end of the administrative battle, and applicants need to budget not only for filing and examination, but also for post-grant defense if the technology is commercially important.
By contrast, the utility model system is procedurally different. Article 143 requires a search request within the specified period after the application passes formal review, provides for publication of the search report, permits applicant objections and third-party views on that report, and allows the Office to grant or reject the utility model after evaluation. But once granted, there is no Article 99 opposition procedure; only court invalidation remains available. That difference can materially affect risk allocation in transactional and litigation planning.
Appeals also matter. Article 100 provides that applicants, patentees, or interested third parties may object to TÜRKPATENT decisions within two months of notification, subject to the specific opposition framework. Businesses should not assume that an unfavorable first-instance administrative decision is final, but they should also not underestimate how quickly Turkish patent deadlines run.
Patent maintenance and portfolio management
Protection in Turkey is not self-sustaining. Article 101 states that annual fees are required throughout the patent term, with the due date tied to the filing date. If the annual fee is not paid on time, Turkish law allows late payment with an additional fee within six months. If payment still is not made, the patent right lapses as of the due date, although the law also contains a mechanism for regaining validity in a limited post-notification period. TÜRKPATENT’s 2026 fee schedule lists annual patent fees from the 3rd year through the 20th year and utility model fees through the 10th year, along with late-payment surcharges and restoration-related items.
In practice, Turkish portfolio management should not be treated as a back-office formality. A valuable Turkish patent can lose force because of missed examination deadlines, missed annual fees, or neglected translation and publication steps in PCT or European patent matters. For multinationals and fast-growing startups alike, Turkish deadlines should be integrated into global docketing, not managed informally.
Filing strategies that work in Turkey
The best filing strategy in Turkey depends on the business model. For a startup or single-jurisdiction innovator focused on the Turkish market, a national filing before TÜRKPATENT may be efficient and commercially sufficient. For a company building a broader international family, the PCT route often makes more sense because it preserves multi-country flexibility while keeping Turkey open for national-phase entry. For applicants already prosecuting before the EPO, the European patent route may offer operational advantages, especially where claim translation and Turkish publication are managed early enough to support provisional protection.
Another strategic choice is whether to file both patent and utility model alternatives. Turkish law expressly allows conversion from a patent application into a utility model application and vice versa, and TÜRKPATENT’s fee schedule includes conversion-related fees. WIPO’s current PCT Applicant’s Guide for Türkiye also notes this conversion possibility under Article 104. That flexibility can be useful when the invention’s strength, budget constraints, or prosecution posture change over time.
Ownership must also be reviewed before filing. Article 113 distinguishes between service inventions and free inventions. An invention made during the employment relationship because of the employee’s assigned activity, or based substantially on the employer’s experience and work, qualifies as a service invention; other inventions are treated as free inventions. The legal framework on employee inventions is supplemented by a dedicated regulation identified in WIPO Lex. For companies operating in Turkey through R&D teams, universities, public projects, or engineering personnel, ownership analysis must happen before filing and certainly before licensing or investment diligence.
Enforcing patents in Turkey
A patent in Turkey is valuable because it confers real exclusionary rights. Article 85 states that the patent owner may prevent, if done without authorization, the making, selling, using, importing, or possessing for such purposes of the patented product; the use of a patented process; the offering of a patented process to others where its prohibited use is known or should be known; and the selling, using, importing, or possessing for such purposes of products obtained directly by the patented process. These rights are broad enough to support serious commercial enforcement against manufacturers, sellers, and importers.
At the same time, Article 85 also defines important carve-outs. Acts done privately for non-commercial purposes, experimental acts involving the patented invention, acts conducted for pharmaceutical regulatory approval including the tests and trials necessary for that approval, and certain magistral pharmacy preparations fall outside the scope of the patent right. These exceptions are highly relevant in freedom-to-operate analysis, especially in life sciences and regulated sectors.
Turkish enforcement can begin earlier than many applicants expect. Under the Industrial Property Code, once the patent or utility model application has been published under Article 97, the applicant is entitled to bring an infringement action. The law further states that if the infringer had been informed of the application or its scope, publication is not decisive, and where the court finds bad faith, infringement may even be recognized before publication. That gives published Turkish applications real pre-grant leverage, particularly in negotiations and urgent market disputes.
Process patents receive an additional evidentiary advantage. The Code provides that where the patent concerns a process for obtaining a product or substance, the court may require the defendant to prove that its process is different. If the product obtained by the patented process is new, every identical product produced without the patentee’s consent is presumed to have been obtained by the patented process unless the contrary is proven, while the defendant’s legitimate interest in protecting manufacturing and trade secrets must still be considered. For process-patent owners, this can be one of the most powerful enforcement tools in Turkish litigation.
Invalidity, non-use, and compulsory licensing
No patent strategy is complete without considering attack risk. Turkish law allows patents to be invalidated where the invention does not meet patentability requirements, where disclosure is insufficient, where the subject matter extends beyond the original application, or where the patent owner lacked entitlement. The law also allows partial invalidity where only some claims are defective. This makes prosecution quality crucial. A weakly drafted Turkish patent may still issue, but it may not survive contested proceedings.
Turkey also recognizes compulsory licensing in defined circumstances. Article 129 provides that a compulsory license may be granted for reasons including non-use, dependency between patents, public interest, public-health export scenarios under the TRIPS amendment framework, certain plant-breeder situations, and anti-competitive conduct by the patent owner. Article 130 then states that anyone may seek a compulsory license where, by the later of three years from publication of the grant or four years from the application date, the patented invention has not started to be used, serious and real steps toward use have not been taken, or use remains insufficient for national market needs. For commercial planning, that means a Turkish patent should not be treated as a purely blocking asset without regard to actual exploitation.
Licensing, collateral, and commercialization
Turkish patent law is not limited to prosecution and litigation. Industrial property rights can be assigned, licensed, pledged, attached, or otherwise made the subject of legal transactions under Article 148, and TÜRKPATENT separately records transfers, licenses, and security interests. TÜRKPATENT’s 2026 patent fee schedule includes recordal and publication fees for pledge or security interests, while TÜRKPATENT’s institutional description confirms that the Office registers license and transfer agreements. WIPO’s 2024 country report further notes that the Turkish IP Code together with the Law on Chattel Mortgage in Commercial Transactions supports the use of IP rights and related intangibles in commercial pledge structures.
This is especially important for startups, technology transfer offices, and investors. A Turkish patent portfolio can support not just market exclusivity, but also fundraising, collateralization, licensing revenue, and transaction value. But that only works if title, inventorship, service-invention status, prosecution history, and maintenance are all clean. In Turkish practice, a commercially weak recordal and ownership chain can undermine what appears on paper to be a strong patent asset.
Final thoughts
Patent protection in Turkey is sophisticated, workable, and commercially significant. The legal system offers a modern statutory framework, multiple filing routes, a functioning examination system, post-grant opposition for patents, a utility model alternative, pre-grant leverage after publication, specialized IP courts, and tools for licensing and collateralization. But the system also expects rigor: patentable subject matter must be identified carefully, filing routes must be chosen strategically, examination deadlines must be watched closely, annual fees must be paid on time, and granted rights must be used and defended intelligently.
For businesses serious about the Turkish market, the best time to think about patents is before product launch, before disclosure, and before distributor rollout. A well-planned Turkish patent position can strengthen exclusivity, negotiation power, valuation, and enforcement readiness. A poorly timed or poorly drafted filing can do the opposite. In Turkey, as in any serious patent jurisdiction, protection starts with strategy, not with paperwork alone.
Yanıt yok